Oric Pharmaceuticals, Inc. - ORIC
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Nimish Shah | 5.8% | 5,676,230 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 5.8% | 5,676,230 | View |
| Jan 21, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.6% | 5,473,145 | View |
| Nov 17, 2025 | SCHEDULE 13G/A | The Column Group II, LP | 3.6% | 3,540,777 | View |
| Nov 17, 2025 | SCHEDULE 13G/A | The Column Group II GP, LP | 3.6% | 3,540,777 | View |
| Nov 17, 2025 | SCHEDULE 13G/A | David V Goeddel | 3.7% | 3,627,493 | View |
| Nov 17, 2025 | SCHEDULE 13G/A | Peter Svennilson | 3.7% | 3,644,118 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Alkeon Capital Management LLC | 4.6% | 4,504,096 | View |
| Nov 13, 2025 | SCHEDULE 13G/A | Panayotis D. Sparaggis | 4.6% | 4,504,096 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.